BACKGROUND: Previous studies in infant rats and case-control studies of human infants undergoing surgery have raised concerns about potential neurodevelopmental toxicities of general anesthesia. Spinal anesthesia is an alternative to general anesthesia for some infant surgeries. To test for potential toxicity, a spinal anesthesia model in infant rats was developed. METHODS: Rats of postnatal ages 7, 14, and 21 days were assigned to no treatment, 1% isoflurane for either 1 h or 6 h, or lumbar spinal injection of saline or bupivacaine at doses of 3.75 mg/kg (low dose) or 7.5 mg/kg (high dose). Subgroups of animals underwent neurobehavioral testing and blood gas analysis. Brain and lumbar spinal cord sections were examined for apoptosis using cleaved caspase-3 immunostaining. The lumbar spinal cord was examined histologically.Rats exposed to spinal or general anesthesia as infants underwent Rotarod testing of motor performance as adults. Data were analyzed using ANOVA with general linear models, Friedman tests, and Mann-Whitney U tests, as appropriate. RESULTS: Bupivacaine 3.75 mg/kg was effective for spinal anesthesia in all age groups. Impairments in sensory and motor function recovered in 40-60 min. Blood gases were similar among groups. Brain and spinal cord apoptosis increased in rats receiving 6 h of 1% isoflurane, but not among the other treatments. All groups showed intact motor performance at adulthood. CONCLUSIONS: Spinal anesthesia is technically feasible in infant rats and appears benign in terms of neuroapoptotic and neuromotor sequelae.
BACKGROUND: Previous studies in infantrats and case-control studies of humaninfants undergoing surgery have raised concerns about potential neurodevelopmental toxicities of general anesthesia. Spinal anesthesia is an alternative to general anesthesia for some infant surgeries. To test for potential toxicity, a spinal anesthesia model in infantrats was developed. METHODS:Rats of postnatal ages 7, 14, and 21 days were assigned to no treatment, 1% isoflurane for either 1 h or 6 h, or lumbar spinal injection of saline or bupivacaine at doses of 3.75 mg/kg (low dose) or 7.5 mg/kg (high dose). Subgroups of animals underwent neurobehavioral testing and blood gas analysis. Brain and lumbar spinal cord sections were examined for apoptosis using cleaved caspase-3 immunostaining. The lumbar spinal cord was examined histologically.Rats exposed to spinal or general anesthesia as infants underwent Rotarod testing of motor performance as adults. Data were analyzed using ANOVA with general linear models, Friedman tests, and Mann-Whitney U tests, as appropriate. RESULTS:Bupivacaine 3.75 mg/kg was effective for spinal anesthesia in all age groups. Impairments in sensory and motor function recovered in 40-60 min. Blood gases were similar among groups. Brain and spinal cord apoptosis increased in rats receiving 6 h of 1% isoflurane, but not among the other treatments. All groups showed intact motor performance at adulthood. CONCLUSIONS: Spinal anesthesia is technically feasible in infantrats and appears benign in terms of neuroapoptotic and neuromotor sequelae.
Authors: A C Scallet; L C Schmued; W Slikker; N Grunberg; P J Faustino; H Davis; D Lester; P S Pine; F Sistare; J P Hanig Journal: Toxicol Sci Date: 2004-07-14 Impact factor: 4.849
Authors: Vesna Jevtovic-Todorovic; Richard E Hartman; Yukitoshi Izumi; Nicholas D Benshoff; Krikor Dikranian; Charles F Zorumski; John W Olney; David F Wozniak Journal: J Neurosci Date: 2003-02-01 Impact factor: 6.167
Authors: Mary Ellen McCann; Jurgen C de Graaff; Liam Dorris; Nicola Disma; Davinia Withington; Graham Bell; Anneke Grobler; Robyn Stargatt; Rodney W Hunt; Suzette J Sheppard; Jacki Marmor; Gaia Giribaldi; David C Bellinger; Penelope L Hartmann; Pollyanna Hardy; Geoff Frawley; Francesca Izzo; Britta S von Ungern Sternberg; Anne Lynn; Niall Wilton; Martin Mueller; David M Polaner; Anthony R Absalom; Peter Szmuk; Neil Morton; Charles Berde; Sulpicio Soriano; Andrew J Davidson Journal: Lancet Date: 2019-02-14 Impact factor: 79.321
Authors: Emre Hamurtekin; Bethany L Fitzsimmons; Veronica I Shubayev; Marjorie R Grafe; Ronald Deumens; Tony L Yaksh; Suellen M Walker Journal: Anesthesiology Date: 2013-07 Impact factor: 7.892
Authors: Frank H Morriss; Shampa Saha; Edward F Bell; Tarah T Colaizy; Barbara J Stoll; Susan R Hintz; Seetha Shankaran; Betty R Vohr; Shannon E G Hamrick; Athina Pappas; Patrick M Jones; Waldemar A Carlo; Abbot R Laptook; Krisa P Van Meurs; Pablo J Sánchez; Ellen C Hale; Nancy S Newman; Abhik Das; Rosemary D Higgins Journal: JAMA Pediatr Date: 2014-08 Impact factor: 16.193